Elvitegravir: A Review of Its Use in Adults with HIV-1 Infection-Reference-Cited by-同舟云学术

Elvitegravir: A Review of Its Use in Adults with HIV-1 Infection

Published:2014-03-27 Issue:6 Volume:74 Page:687-697
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Deeks Emma D.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

http://link.springer.com/content/pdf/10.1007/s40265-014-0206-8.pdf

Reference48 articles.

1. Arts EJ, Hazuda DJ. HIV-1 antiretroviral drug therapy. Cold Spring Harb Perspect Med. 2012;2(4):a007161.

2. Detels R, Munoz A, McFarlane G, et al. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. JAMA. 1998;280(17):1497–503.

3. Williams I, Churchill D, Anderson J, et al. British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight). HIV Med. 2014;15(Suppl 1):1–6.

4. European AIDS Clinical Society. Guidelines version 7.0. 2013. http://www.eacsociety.org/Portals/0/Guidelines_Online_131014.pdf . Accessed 17 Mar 2014.

5. Karmon SL, Markowitz M. Next-generation integrase inhibitors: where to after raltegravir? Drugs. 2013;73(3):213–28.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges in development of antiviral drugs and vaccines;Pathogenic Viruses and Armamentarium Design;2024

2. Antiviral drugs: Types and mechanism of action;Pathogenic Viruses and Armamentarium Design;2024

3. Fluorine in anti-HIV drugs approved by FDA from 1981 to 2023;European Journal of Medicinal Chemistry;2023-10

4. Quinolines and isoquinolines as HIV-1 inhibitors: Chemical structures, action targets, and biological activities;Bioorganic Chemistry;2023-07

5. Quinolone: a versatile therapeutic compound class;Molecular Diversity;2022-12-17